+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cervical Cancer Drugs Market Research Reports

Cervical Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Cervical Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1768 Pages
From
Vaginal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Vaginal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 475 Pages
From
From
Cervical Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Cervical Cancer - Epidemiology Forecast to 2030

  • Report
  • October 2020
  • 100 Pages
From
Bevacizumab - Biosimilars Insight, 2020 - Product Thumbnail Image

Bevacizumab - Biosimilars Insight, 2020

  • Report
  • August 2020
  • 125 Pages
From
From
From
From
From
Human papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2020 - Product Thumbnail Image

Human papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
From
From
From
From
From
Cervical Cancer - Epidemiology Insights to 2023 - Product Thumbnail Image

Cervical Cancer - Epidemiology Insights to 2023

  • Report
  • June 2017
  • 40 Pages
From
Loading Indicator

Cervical cancer is the second most common and the fifth most deadly cancer in women. Approximately 80% of cervical cancers occur in developing countries which makes emerging economies such as China a major target market for pharmaceutical companies in the cervical cancer sector. The following expert reports enable buyers to examine the essential issues: supply and demand, forecasts, drug development and discovery, licensing, SWOT analyses, key industry players and more. This is the place for the inside track on market entry opportunities, growth strategies, buyer solutions and potential industry alliances in the area of cervical cancer drug development. Show Less Read more

adroll